Multiparametric MRI is not sufficient for prostate cancer staging: A single institutional experience validated by a multi-institutional regional collaborative-Reference-Cited by-同舟云学术

Multiparametric MRI is not sufficient for prostate cancer staging: A single institutional experience validated by a multi-institutional regional collaborative

Published:2023-08 Issue:8 Volume:41 Page:355.e1-355.e8
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Chandrasekar Thenappan^ORCID,Denisenko Andrew^ORCID,Mico Vasil,McPartland Connor,Shah Yash,Mark James R.,Lallas Costas D.,Fonshell Claudette,Danella John,Jacobs Bruce,Lanchoney Thomas,Raman Jay D.,Tomaszewski Jeffrey,Reese Adam,Singer Eric A.,Ginzburg Serge,Smaldone Marc,Uzzo Robert,Guzzo Thomas J.,Trabulsi Edouard J.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference29 articles.

1. Multiparametric magnetic resonance imaging: current role in prostate cancer management;Ueno;Int J Urol,2016

2. Concordance between preoperative mpMRI and pathological stage and its influence on nerve-sparing surgery in patients with high-risk prostate cancer;Humke;Curr Oncol,2022

3. Multiparametric magnetic resonance imaging grades the aggressiveness of prostate cancer;Morote;Cancers (Basel),2022

4. Comparison of magnetic resonance imaging and transrectal ultrasound informed prostate biopsy for prostate cancer diagnosis in biopsy naïve men: a systematic review and meta-analysis;Goldberg;J Urol,2020

5. MRI-targeted or standard biopsy in prostate cancer screening;Eklund;N Engl J Med,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The 2012 Briganti nomogram not only predicts lymph node involvement but also disease progression in surgically treated intermediate-risk prostate cancer patients with PSA <10 ng/mL, ISUP grade group 3, and clinical stage up to cT2b;International braz j urol;2024-08

2. 2012 Briganti nomogram predict prostate cancer progression in EAU intermediate risk with unfavorable tumor grade: A single center experience;Urologia Journal;2024-05-23

3. The 2012 Briganti nomogram predicts disease progression in surgically treated intermediate-risk prostate cancer patients with favorable tumor grade group eventually associated with some adverse factors;Journal of Robotic Surgery;2024-03-23

4. Re: Multiparametric MRI is not sufficient for prostate cancer staging: A single institutional experience validated by a multi-institutional regional collaborative. Thenappan Chandrasekar, Andrew Denisenko, Vasil Mico and Colleagues. Urological Oncology: Seminars and Original Investigations 41 (2023) 355.e1-355.e8;Urologic Oncology: Seminars and Original Investigations;2024-01